X0206 3 2021-04-22 0 0001724979 Rain Therapeutics Inc. RAIN 0001856681 Doebele Robert C/O RAIN THERAPEUTICS INC. 8000 JARVIS AVENUE, SUITE 204 NEWARK CA 94560 0 1 0 0 EVP, Chief Scientific Officer Common Stock 463005 D Series A Preferred Stock Common Stock 4932 D Stock Option (Right to Buy) 4.00 2030-11-12 Common Stock 92601 D Stock Option (Right to Buy) 3.13 2030-06-24 Common Stock 9260 D Stock Option (Right to Buy) 3.95 2029-10-31 Common Stock 9260 D Stock Option (Right to Buy) 3.95 2029-05-14 Common Stock 13890 D Stock Option (Right to Buy) 3.95 2029-03-13 Common Stock 13890 D Each share of Series A Preferred Stock is convertible into common stock on a one-for-1.0799 basis into the number of shares of common stock shown in column 3 at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock has no expiration date. This option represents a right to purchase a total of 92,601 shares of the Issuer's common stock, one quarter of which will vest on October 1, 2021, with the remaining three quarters vesting in equal monthly installments through October 1, 2024, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 9,260 shares of the Issuer's common stock, one half of which will vest on May 29, 2021, with the remaining half vesting in equal quarterly installments through May 29, 2022, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 9,260 shares of the Issuer's common stock, one half of which vested on November 13, 2020, with the remaining half vesting in equal quarterly installments through November 13, 2021, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 13,890 shares of the Issuer's common stock, one half of which vested on May 15, 2020, with the remaining half vesting in equal quarterly installments through May 15, 2021, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 13,890 shares of the Issuer's common stock, which is vested in full. Exhibit 24 - Power of Attorney /s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele 2021-04-22